MedTrace Logo

Allergy Antibiotics And Microbial Resistance

NCT04108637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 823

Last updated 2024-06-05

No results posted yet for this study

Summary

ALBAMA study is designed to find out if the effects of Penicillin allergy assessment pathway (PAAP) intervention is on penicillin prescribing

Conditions

Interventions

PROCEDURE

penicillin allergy assessment pathway

Summary of penicillin allergy assessment pathway : Stage-1 PAAP in Primary Care - Clinical History. Screening, questionnaire and antimicrobial history will be undertaken in primary care Stage-2 Skin Test(ST) in hospital clinic (this may not be needed for all participants) Stage 3 Oral Challenge Test (OCT) in hospital clinic Testing will involve half a day in clinic and then a three-day post clinic course of oral antimicrobial therapy, without a reaction

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • University of Leeds

    lead OTHER

Principal Investigators

  • Jonathan Sandoe, Dr · University of Leeds

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-04
Primary Completion
2024-02-29
Completion
2024-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04108637 on ClinicalTrials.gov